Evidence map›Paper›PMID 40305372›Full record

ArticleEmerging infectious diseases2025

Self-Reported SARS-CoV-2 Infections among National Blood Donor Cohort, United States, 2020-2022.

Bryan R Spencer, Akintunde Akinseye, Eduard Grebe, Mars Stone, Karla G Zurita, David J Wright, James M Haynes, Susan L Stramer, Michael P Busch

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Bryan R Spencer
Akintunde Akinseye
Eduard Grebe
Mars Stone
Karla G Zurita
David J Wright
James M Haynes
Susan L Stramer
Michael P Busch

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

SARS-CoV-2 case surveillance in the United States did not distinguish first infections from reinfections. In a large blood donor cohort, self-reported first infections and reinfections during 2020-2022 mirrored public health case count surveillance, and reinfection incidence peaked in 2022. Blood donor data could aid in SARS-CoV-2 and emerging infectious disease surveillance.

Indexed as

Blood DonorsCOVID-19SARS-CoV-2AdultCohort StudiesFemaleHumansIncidenceMaleMiddle AgedReinfectionSelf ReportUnited StatesYoung Adultblood donorsCOVID-19health surveyspublic health surveillancerespiratory infectionsSARS-CoV-2United Statesviruses

Identifiers

PMID40305372
PMCPMC12044225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.